Table 1. Details of 12 SLE patients.
Patient | Age | Disease duration | Current treated | SLEDAI |
1 | 27 | 1 year | Pred 12.5mg/day | 4 |
HCQ 0.2g/day | ||||
CTX 0.4g/2 weeks | ||||
2 | 43 | 19 years | Pred 10mg/day | 8 |
HCQ 0.2g/day | ||||
CTX 0.4g/2 weeks | ||||
3 | 40 | 2 years | Pred 15mg/day | 4 |
HCQ 0.2g/day | ||||
4 | 23 | 3 years | Pred 15mg/day | 4 |
HCQ 0.2g/day | ||||
MTX 5mg/1 week | ||||
5 | 31 | 5 years | Pred 7.5mg/day | 1 |
6 | 26 | 9 years | Pred 10mg/day | 2 |
7 | 13 | 4 years | Pred 12.5mg/day | 11 |
HCQ 0.2g/day | ||||
8 | 25 | 5 years | Pred 15mg/day | 16 |
HCQ 0.2g/day | ||||
CTX 0.4g/2 weeks | ||||
9 | 25 | 8 years | Pred 10mg/day | 8 |
HCQ 0.2g/day | ||||
10 | 31 | 6 years | Pred 15mg/day | 8 |
HCQ 0.2g/day | ||||
11 | 35 | 7 years | Pred 15mg/day | 10 |
HCQ 0.2g/day | ||||
12 | 23 | 2 years | none | 5 |